186 related articles for article (PubMed ID: 18256860)
1. The use and toxicity of steroids in the management of patients with brain metastases.
Sturdza A; Millar BA; Bana N; Laperriere N; Pond G; Wong RK; Bezjak A
Support Care Cancer; 2008 Sep; 16(9):1041-8. PubMed ID: 18256860
[TBL] [Abstract][Full Text] [Related]
2. The impact of RTOG 0614 and RTOG 0933 trials in routine clinical practice: The US Survey of Utilization of Memantine and IMRT planning for hippocampus sparing in patients receiving whole brain radiotherapy for brain metastases.
Slade AN; Stanic S
Contemp Clin Trials; 2016 Mar; 47():74-7. PubMed ID: 26718093
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone treatment in patients with brain metastases and primary brain tumors: do the benefits outweigh the side-effects?
Hempen C; Weiss E; Hess CF
Support Care Cancer; 2002 May; 10(4):322-8. PubMed ID: 12029432
[TBL] [Abstract][Full Text] [Related]
4. Defining the impact and contribution of steroids in patients receiving whole-brain irradiation for cerebral metastases.
Millar BM; Bezjak A; Tsao M; Sturdza A; Laperriere N
Clin Oncol (R Coll Radiol); 2004 Aug; 16(5):339-44. PubMed ID: 15341437
[TBL] [Abstract][Full Text] [Related]
5. Practice Variation in Perioperative Steroid Dosing for Brain Tumor Patients: An International Survey.
Jessurun CAC; Hulsbergen AFC; Lamba N; Nandoe Tewarie RDS; Smith TR; Broekman MLD
World Neurosurg; 2022 Mar; 159():e431-e441. PubMed ID: 34958992
[TBL] [Abstract][Full Text] [Related]
6. Gastric cancer and metastasis to the brain.
York JE; Stringer J; Ajani JA; Wildrick DM; Gokaslan ZL
Ann Surg Oncol; 1999 Dec; 6(8):771-6. PubMed ID: 10622506
[TBL] [Abstract][Full Text] [Related]
7. A prospective survey of the use of dexamethasone on a palliative care unit.
Hardy JR; Rees E; Ling J; Burman R; Feuer D; Broadley K; Stone P
Palliat Med; 2001 Jan; 15(1):3-8. PubMed ID: 11212465
[TBL] [Abstract][Full Text] [Related]
8. The Use of Corticosteroids as Adjuvant Therapy for Painful Bone Metastases: A Large Cross-Sectional Survey of Palliative Care Providers.
White P; Arnold R; Bull J; Cicero B
Am J Hosp Palliat Care; 2018 Jan; 35(1):151-158. PubMed ID: 28273755
[TBL] [Abstract][Full Text] [Related]
9. Steroid myopathy in cancer patients.
Batchelor TT; Taylor LP; Thaler HT; Posner JB; DeAngelis LM
Neurology; 1997 May; 48(5):1234-8. PubMed ID: 9153449
[TBL] [Abstract][Full Text] [Related]
10. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Steroids in the Treatment of Adults With Metastatic Brain Tumors.
Ryken TC; Kuo JS; Prabhu RS; Sherman JH; Kalkanis SN; Olson JJ
Neurosurgery; 2019 Mar; 84(3):E189-E191. PubMed ID: 30629207
[TBL] [Abstract][Full Text] [Related]
11. A Reduced Exogenous Steroid Taper for Postoperative Brain Tumor Patients-A Case-Control Study.
Breshears JD; Haddad AF; Viner J; Rau J; Sankaran S; McDermott MW
World Neurosurg; 2019 May; 125():e44-e47. PubMed ID: 30639502
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone prescribing for cancer pain between palliative care and radiation oncology.
Jeong A; Wade K
Support Care Cancer; 2022 Sep; 30(9):7689-7696. PubMed ID: 35689675
[TBL] [Abstract][Full Text] [Related]
13. The relationship between corticosteroids and symptoms in patients with primary brain tumors: utility of the Dexamethasone Symptom Questionnaire-Chronic.
Armstrong TS; Ying Y; Wu J; Acquaye AA; Vera-Bolanos E; Gilbert MR; Brown PD; Vardy J; Chung C
Neuro Oncol; 2015 Aug; 17(8):1114-20. PubMed ID: 25862766
[TBL] [Abstract][Full Text] [Related]
14. The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline.
Ryken TC; McDermott M; Robinson PD; Ammirati M; Andrews DW; Asher AL; Burri SH; Cobbs CS; Gaspar LE; Kondziolka D; Linskey ME; Loeffler JS; Mehta MP; Mikkelsen T; Olson JJ; Paleologos NA; Patchell RA; Kalkanis SN
J Neurooncol; 2010 Jan; 96(1):103-14. PubMed ID: 19957014
[TBL] [Abstract][Full Text] [Related]
15. A phase I trial of human corticotropin-releasing factor (hCRF) in patients with peritumoral brain edema.
Villalona-Calero MA; Eckardt J; Burris H; Kraynak M; Fields-Jones S; Bazan C; Lancaster J; Hander T; Goldblum R; Hammond L; Bari A; Drengler R; Rothenberg M; Hadovsky G; Von Hoff DD
Ann Oncol; 1998 Jan; 9(1):71-7. PubMed ID: 9541686
[TBL] [Abstract][Full Text] [Related]
16. Physician expectations of treatment outcomes for patients with brain metastases referred for whole brain radiotherapy.
Barnes EA; Chow E; Tsao MN; Bradley NM; Doyle M; Li K; Lam K; Danjoux C
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):187-92. PubMed ID: 19386437
[TBL] [Abstract][Full Text] [Related]
17. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients.
Lagerwaard FJ; Levendag PC; Nowak PJ; Eijkenboom WM; Hanssens PE; Schmitz PI
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):795-803. PubMed ID: 10098435
[TBL] [Abstract][Full Text] [Related]
18. Outcomes after whole brain reirradiation in patients with brain metastases.
Son CH; Jimenez R; Niemierko A; Loeffler JS; Oh KS; Shih HA
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e167-72. PubMed ID: 21620583
[TBL] [Abstract][Full Text] [Related]
19. Twice-daily tapering dexamethasone treatment during cranial radiation for newly diagnosed brain metastases.
Weissman DE; Janjan NA; Erickson B; Wilson FJ; Greenberg M; Ritch PS; Anderson T; Hansen RM; Chitambar CR; Lawton CA
J Neurooncol; 1991 Dec; 11(3):235-9. PubMed ID: 1726656
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapeutic management of brain metastases: a systematic review and meta-analysis.
Tsao MN; Lloyd NS; Wong RK; Rakovitch E; Chow E; Laperriere N;
Cancer Treat Rev; 2005 Jun; 31(4):256-73. PubMed ID: 15951117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
